Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics, Inc.

0.0194
0.0000
Volume:10.68K
Turnover:197.59
Market Cap:- -
PE:0.00
High:0.0195
Open:0.0148
Low:0.0148
Close:0.0194
52wk High:0.0440
52wk Low:0.0102
Shares:- -
Float Shares:- -
Volume Ratio:6.37
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-28.3716
ROE:-203.36%
ROA:-96.45%
PB:0.00
PE(LYR):- -

Loading ...

Jan 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Correspondence

Form CORRESP - Correspondence
Jul 07, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 01, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 24, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 28, 2023

Major Issues Report

Form 8-K - Current report
Mar 28, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]